Correction to: Therapeutic potential of NGF-enriched extracellular vesicles in modulating neuroinflammation and enhancing peripheral nerve remyelination (Acta Neuropathologica Communications, (2025), 13, 1, (118), 10.1186/s40478-025-02033-9)

2Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the sentence beginning ‘Specifically, the expression level of … the two groups (Supplementary Figure. 4).’ In Effect of NCCoe-NGF-EVs on LPS-induced neuronal inflammation under the Results section of this article [1], the terms ‘IL-6’ and ‘IL-1β’ were placed incorrectly in the sentence. The corrected sentence is “Specifically, the expression level of TNF-α, COX-2, and IL-1β in NCCoe-NGF-EVs was lower than those in the NCC-EVs group, while the expression level of IL-6 was higher (Supplementary Figure. 4)”. The original article has been corrected.

Cite

CITATION STYLE

APA

Yeo, H., Kim, Y. J., Seok, J., Kwak, Y., Jang, S. B., Lim, N. H., … Cho, S. G. (2025, December 1). Correction to: Therapeutic potential of NGF-enriched extracellular vesicles in modulating neuroinflammation and enhancing peripheral nerve remyelination (Acta Neuropathologica Communications, (2025), 13, 1, (118), 10.1186/s40478-025-02033-9). Acta Neuropathologica Communications . BioMed Central Ltd. https://doi.org/10.1186/s40478-025-02108-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free